These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 17537869

  • 21. Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat.
    Mountfield RJ, Kiehr B, John BA.
    Drug Metab Dispos; 2000 May; 28(5):503-13. PubMed ID: 10772628
    [Abstract] [Full Text] [Related]

  • 22. Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers.
    Waldmeier F, Glaenzel U, Wirz B, Oberer L, Schmid D, Seiberling M, Valencia J, Riviere GJ, End P, Vaidyanathan S.
    Drug Metab Dispos; 2007 Aug; 35(8):1418-28. PubMed ID: 17510248
    [Abstract] [Full Text] [Related]

  • 23. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
    Prakash C, Cui D, Baxter JG, Bright GM, Miceli J, Wilner K.
    Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
    [Abstract] [Full Text] [Related]

  • 24. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
    Mamidi RN, Mannens G, Annaert P, Hendrickx J, Goris I, Bockx M, Janssen CG, Kao M, Kelley MF, Meuldermans W.
    Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
    [Abstract] [Full Text] [Related]

  • 25. Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
    Balani SK, Woolf EJ, Hoagland VL, Sturgill MG, Deutsch PJ, Yeh KC, Lin JH.
    Drug Metab Dispos; 1996 Dec; 24(12):1389-94. PubMed ID: 8971147
    [Abstract] [Full Text] [Related]

  • 26. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM, D'Souza RA, Jordan AC, King CD, Smith SM, Phillips PJ, McCormick AD, Roberts DW.
    J Pharm Biomed Anal; 2007 Feb 19; 43(3):1065-77. PubMed ID: 17030109
    [Abstract] [Full Text] [Related]

  • 27. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M, Bordini E, Fizzotti P, Roberts A, Johnson BM.
    Drug Metab Dispos; 2009 Aug 19; 37(8):1635-45. PubMed ID: 19420128
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
    Ericsson H, Hamrén B, Bergstrand S, Elebring M, Fryklund L, Heijer M, Ohman KP.
    Drug Metab Dispos; 2004 Sep 19; 32(9):923-9. PubMed ID: 15319332
    [Abstract] [Full Text] [Related]

  • 29. Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers.
    Paulson SK, Hribar JD, Liu NW, Hajdu E, Bible RH, Piergies A, Karim A.
    Drug Metab Dispos; 2000 Mar 19; 28(3):308-14. PubMed ID: 10681375
    [Abstract] [Full Text] [Related]

  • 30. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C, Cui D.
    Drug Metab Dispos; 1997 Dec 19; 25(12):1395-406. PubMed ID: 9394030
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics, metabolism, and routes of excretion of intravenous irofulven in patients with advanced solid tumors.
    Paci A, Rezai K, Deroussent A, De Valeriola D, Re M, Weill S, Cvitkovic E, Kahatt C, Shah A, Waters S, Weems G, Vassal G, Lokiec F.
    Drug Metab Dispos; 2006 Nov 19; 34(11):1918-26. PubMed ID: 16896064
    [Abstract] [Full Text] [Related]

  • 32. Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.
    Vyas KP, Halpin RA, Geer LA, Ellis JD, Liu L, Cheng H, Chavez-Eng C, Matuszewski BK, Varga SL, Guiblin AR, Rogers JD.
    Drug Metab Dispos; 2000 Jan 19; 28(1):89-95. PubMed ID: 10611145
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infections.
    Van Wart SA, Owen JS, Ludwig EA, Meagher AK, Korth-Bradley JM, Cirincione BB.
    Antimicrob Agents Chemother; 2006 Nov 19; 50(11):3701-7. PubMed ID: 16940069
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Population pharmacokinetics of tigecycline in healthy volunteers.
    Van Wart SA, Cirincione BB, Ludwig EA, Meagher AK, Korth-Bradley JM, Owen JS.
    J Clin Pharmacol; 2007 Jun 19; 47(6):727-37. PubMed ID: 17519399
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.